Work

First-in-class anti-PVR mAb NTX1088 restores DNAM1 expression and enhances antitumor immunity

Year: 2022

Type: article

Source: European Journal of Cancer

DOI: 10.1016/s0959-8049(22)00987-x

Authors: A. Atieh, A. Obiedat, A. Vitenshtein, G. Cinamon, K. Paz, T. Roviš, P. Kucan, L. Hirsl, O. Mandelboim, S. Jonjic, T. Pini

Institution: Hebrew University of Jerusalem

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4307906976

FWCI: 0.105

Cites:

Cited by: 1

Related to: 10